{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T02:33:23Z","timestamp":1789526003313,"version":"build-2803163510"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":2450,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.virol.2006.07.017","type":"journal-article","created":{"date-parts":[[2006,8,22]],"date-time":"2006-08-22T07:31:02Z","timestamp":1156231862000},"page":"164-174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Immunogenicity and protection efficacy of monovalent and polyvalent poxvirus vaccines that include the D8 antigen"],"prefix":"10.1016","volume":"355","author":[{"given":"Pavlo","family":"Sakhatskyy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Te-hui W.","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.virol.2006.07.017_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1099\/0022-1317-13-1-9","article-title":"An antigenic difference between intracellular and extracellular rabbitpox virus","volume":"13","author":"Appleyard","year":"1971","journal-title":"J. Gen. Virol."},{"issue":"25","key":"10.1016\/j.virol.2006.07.017_bib2","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1016\/j.vaccine.2005.01.079","article-title":"A novel, cell culture-derived smallpox vaccine in vaccinia-naive adults","volume":"23","author":"Artenstein","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2006.07.017_bib3","first-page":"86","article-title":"Differences between extracellular and intracellular forms of poxvirus and their implications","volume":"16","author":"Boulter","year":"1973","journal-title":"Prog. Med. Virol."},{"issue":"11","key":"10.1016\/j.virol.2006.07.017_bib4","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/ni727","article-title":"Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung","volume":"2","author":"Chen","year":"2001","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.virol.2006.07.017_bib5","first-page":"30","article-title":"Insertion mutants of the vaccinia virus. The effect of inactivating E7R and D8L genes on the biological properties of the virus","author":"Chernos","year":"1993","journal-title":"Mol. Gen. Mikrobiol. Virusol."},{"issue":"2","key":"10.1016\/j.virol.2006.07.017_bib6","first-page":"151","article-title":"Amino acid sequence determination of vaccinia virus immunodominant protein p35 and identification of the gene","volume":"2","author":"Chertov","year":"1991","journal-title":"Biomed. Sci."},{"issue":"10","key":"10.1016\/j.virol.2006.07.017_bib7","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.4049\/jimmunol.171.10.4969","article-title":"Cutting edge: long-term B cell memory in humans after smallpox vaccination","volume":"171","author":"Crotty","year":"2003","journal-title":"J. Immunol."},{"issue":"18","key":"10.1016\/j.virol.2006.07.017_bib8","doi-asserted-by":"crossref","first-page":"11724","DOI":"10.1128\/JVI.79.18.11724-11733.2005","article-title":"Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice","volume":"79","author":"Davies","year":"2005","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2006.07.017_bib9","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1128\/jvi.66.1.386-398.1992","article-title":"Identification and characterization of vaccinia virus genes encoding proteins that are highly antigenic in animals and are immunodominant in vaccinated humans","volume":"66","author":"Demkowicz","year":"1992","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.virol.2006.07.017_bib10","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1128\/jvi.70.4.2627-2631.1996","article-title":"Human cytotoxic T-cell memory: long-lived responses to vaccinia virus","volume":"70","author":"Demkowicz","year":"1996","journal-title":"J. Virol."},{"issue":"6979","key":"10.1016\/j.virol.2006.07.017_bib11","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature02331","article-title":"Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox","volume":"428","author":"Earl","year":"2004","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.virol.2006.07.017_bib12","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1006\/viro.1993.1302","article-title":"The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence","volume":"194","author":"Engelstad","year":"1993","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.virol.2006.07.017_bib13","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0042-6822(92)90535-W","article-title":"A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope","volume":"188","author":"Engelstad","year":"1992","journal-title":"Virology"},{"issue":"11","key":"10.1016\/j.virol.2006.07.017_bib14","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1086\/340517","article-title":"Primary induction of human CD8+ cytotoxic T lymphocytes and interferon-gamma-producing T cells after smallpox vaccination","volume":"185","author":"Ennis","year":"2002","journal-title":"J. Infect. Dis."},{"issue":"19","key":"10.1016\/j.virol.2006.07.017_bib15","doi-asserted-by":"crossref","first-page":"10230","DOI":"10.1128\/JVI.78.19.10230-10237.2004","article-title":"Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions","volume":"78","author":"Fogg","year":"2004","journal-title":"J. Virol."},{"issue":"12","key":"10.1016\/j.virol.2006.07.017_bib16","doi-asserted-by":"crossref","first-page":"5988","DOI":"10.1128\/jvi.64.12.5988-5996.1990","article-title":"Use of a cell-free system to identify the vaccinia virus L1R gene product as the major late myristylated virion protein M25","volume":"64","author":"Franke","year":"1990","journal-title":"J. Virol."},{"issue":"17","key":"10.1016\/j.virol.2006.07.017_bib17","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1056\/NEJMoa013431","article-title":"Dose-related effects of smallpox vaccine","volume":"346","author":"Frey","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.virol.2006.07.017_bib18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/viro.1998.9516","article-title":"Neutralizing and protective antibodies directed against vaccinia virus envelope antigens","volume":"254","author":"Galmiche","year":"1999","journal-title":"Virology"},{"issue":"5406","key":"10.1016\/j.virol.2006.07.017_bib19","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1126\/science.283.5406.1279","article-title":"The looming threat of bioterrorism","volume":"283","author":"Henderson","year":"1999","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.virol.2006.07.017_bib20","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1006\/viro.1999.0096","article-title":"DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge","volume":"266","author":"Hooper","year":"2000","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.virol.2006.07.017_bib21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0042-6822(02)00038-7","article-title":"Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates","volume":"306","author":"Hooper","year":"2003","journal-title":"Virology"},{"issue":"9","key":"10.1016\/j.virol.2006.07.017_bib22","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1128\/JVI.78.9.4433-4443.2004","article-title":"Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox","volume":"78","author":"Hooper","year":"2004","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.virol.2006.07.017_bib23","doi-asserted-by":"crossref","first-page":"8750","DOI":"10.1128\/JVI.73.10.8750-8761.1999","article-title":"Vaccinia virus envelope D8L protein binds to cell surface chondroitin sulfate and mediates the adsorption of intracellular mature virions to cells","volume":"73","author":"Hsiao","year":"1999","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.virol.2006.07.017_bib24","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2174\/1568005054201517","article-title":"Application of the polyvalent approach to HIV-1 vaccine development","volume":"5","author":"Hurwitz","year":"2005","journal-title":"Curr. Drug Targets Infect. Disord."},{"issue":"2","key":"10.1016\/j.virol.2006.07.017_bib25","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1006\/viro.1996.0337","article-title":"Neutralizing epitope on penetration protein of vaccinia virus","volume":"220","author":"Ichihashi","year":"1996","journal-title":"Virology"},{"issue":"7","key":"10.1016\/j.virol.2006.07.017_bib26","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1086\/423848","article-title":"Induction of human T cell-mediated immune responses after primary and secondary smallpox vaccination","volume":"190","author":"Kennedy","year":"2004","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.virol.2006.07.017_bib27","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1006\/viro.2000.0750","article-title":"Antibody neutralization of the extracellular enveloped form of vaccinia virus","volume":"280","author":"Law","year":"2001","journal-title":"Virology"},{"issue":"7","key":"10.1016\/j.virol.2006.07.017_bib28","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1128\/JVI.74.7.3353-3365.2000","article-title":"Vaccinia virus envelope H3L protein binds to cell surface heparan sulfate and is important for intracellular mature virion morphogenesis and virus infection in vitro and in vivo","volume":"74","author":"Lin","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2006.07.017_bib29","first-page":"355","article-title":"Antigen engineering in DNA immunization","volume":"vol. 29","author":"Lu","year":"1998"},{"issue":"3","key":"10.1016\/j.virol.2006.07.017_bib30","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0021-9258(19)40055-0","article-title":"Structural and functional characterization of a cell surface binding protein of vaccinia virus","volume":"265","author":"Maa","year":"1990","journal-title":"J. Biol. Chem."},{"issue":"25\u201326","key":"10.1016\/j.virol.2006.07.017_bib31","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1016\/j.vaccine.2004.02.034","article-title":"Differential efficacy of vaccinia virus envelope proteins administered by DNA immunisation in protection of BALB\/c mice from a lethal intranasal poxvirus challenge","volume":"22","author":"Pulford","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2006.07.017_bib32","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1099\/0022-1317-83-5-1059","article-title":"Administration to mice of a monoclonal antibody that neutralizes the intracellular mature virus form of vaccinia virus limits virus replication efficiently under prophylactic and therapeutic conditions","volume":"83","author":"Ramirez","year":"2002","journal-title":"J. Gen. Virol."},{"issue":"1","key":"10.1016\/j.virol.2006.07.017_bib33","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0042-6822(90)90477-9","article-title":"Inducible gene expression from vaccinia virus vectors","volume":"177","author":"Rodriguez","year":"1990","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.virol.2006.07.017_bib34","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1084\/jem.179.6.1933","article-title":"Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses","volume":"179","author":"Selin","year":"1994","journal-title":"J. Exp. Med."},{"issue":"9","key":"10.1016\/j.virol.2006.07.017_bib35","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1084\/jem.188.9.1705","article-title":"Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations","volume":"188","author":"Selin","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.virol.2006.07.017_bib36","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1099\/0022-1317-80-10-2751","article-title":"A model for vaccinia virus pathogenesis and immunity based on intradermal injection of mouse ear pinnae","volume":"80","author":"Tscharke","year":"1999","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2006.07.017_bib37","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1099\/0022-1317-83-8-1977","article-title":"Dermal infection with vaccinia virus reveals roles for virus proteins not seen using other inoculation routes","volume":"83","author":"Tscharke","year":"2002","journal-title":"J. Gen. Virol."},{"issue":"1","key":"10.1016\/j.virol.2006.07.017_bib38","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1006\/viro.2001.1131","article-title":"The A17L gene product of vaccinia virus is exposed on the surface of IMV","volume":"290","author":"Wallengren","year":"2001","journal-title":"Virology"},{"issue":"25\u201326","key":"10.1016\/j.virol.2006.07.017_bib39","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1016\/j.vaccine.2004.02.036","article-title":"A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague","volume":"22","author":"Wang","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2006.07.017_bib40","first-page":"185","article-title":"Delivery of DNA to skin by particle bombardment","volume":"245","author":"Wang","year":"2004","journal-title":"Methods Mol. Biol."},{"issue":"3","key":"10.1016\/j.virol.2006.07.017_bib41","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1128\/JVI.79.3.1906-1910.2005","article-title":"Identification of two neutralizing regions on the severe acute respiratory syndrome coronavirus spike glycoprotein produced from the mammalian expression system","volume":"79","author":"Wang","year":"2005","journal-title":"J. Virol."},{"issue":"21","key":"10.1016\/j.virol.2006.07.017_bib42","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1016\/j.vaccine.2005.08.023","article-title":"Relative contributions of codon usage, promoter efficiency and leader sequence to the antigen expression and immunogenicity of HIV-1 Env DNA vaccine","volume":"24","author":"Wang","year":"2006","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.virol.2006.07.017_bib43","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/nm916","article-title":"Clonal vaccinia virus grown in cell culture as a new smallpox vaccine","volume":"9","author":"Weltzin","year":"2003","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.virol.2006.07.017_bib44","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1006\/viro.1995.1378","article-title":"A myristylated membrane protein encoded by the vaccinia virus L1R open reading frame is the target of potent neutralizing monoclonal antibodies","volume":"211","author":"Wolffe","year":"1995","journal-title":"Virology"},{"issue":"13","key":"10.1016\/j.virol.2006.07.017_bib45","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.1073\/pnas.0401165101","article-title":"Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge","volume":"101","author":"Wyatt","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682206004752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682206004752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T23:43:40Z","timestamp":1758584620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682206004752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S0042682206004752"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2006.07.017","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and protection efficacy of monovalent and polyvalent poxvirus vaccines that include the D8 antigen","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2006.07.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}